These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8111834)

  • 1. [Present status in the development of new antineoplastic agents].
    Klener P
    Cas Lek Cesk; 1994 Jan; 133(1):6-9. PubMed ID: 8111834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Disorders of the cardiovascular system during treatment of oncologic diseases].
    Elbl L
    Vnitr Lek; 2002 Jul; 48(7):619-25. PubMed ID: 12197403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Perspectives of medical therapy of solid tumours].
    Koza I
    Vnitr Lek; 2001 Aug; 47(8):510-5. PubMed ID: 15633386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
    Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New trends in antineoplastic chemotherapy].
    Klener P
    Vnitr Lek; 1994 Jun; 40(6):386-90. PubMed ID: 8073651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-emetic therapy in cancer chemotherapy: current status.
    Herrstedt J; Dombernowsky P
    Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):143-50. PubMed ID: 17697032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of formation of micronuclei in SCC VII murine cells treated with various chemotherapeutic agents].
    Jeremić B; Sibamoto J; Abe M
    Srp Arh Celok Lek; 1996; 124(7-8):169-74. PubMed ID: 9102841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of new anti-cancer agents.
    Lobbezoo MW; Krul MR; Pinedo HM
    Forum (Genova); 1999; 9(3 Suppl 3):47-53. PubMed ID: 10607846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of new antineoplastic agents: 10 years of active clinical research marked by the evolution of treatment, from an empirical to a rational approach].
    Awada A
    Bull Mem Acad R Med Belg; 2001; 156(6 Pt 2):338-47. PubMed ID: 11928224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closing Remarks.
    Reed E
    Oncologist; 1996; 1(4):276-277. PubMed ID: 10388002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of cytostatic drugs by nurses: analysis of preliminary results].
    Bilski B
    Med Pr; 2004; 55(3):243-7. PubMed ID: 15493499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High-dose chemotherapy--a new hope for some patients with malignant tumors?].
    Mayer J
    Vnitr Lek; 1997 Dec; 43(12):809-14. PubMed ID: 9601895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
    Wietrzyk J; Nevozhay D; Filip B; Milczarek M; Kutner A
    Anticancer Res; 2007; 27(5A):3387-98. PubMed ID: 17970085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. If 'atypical' neuroleptics did not exist, it wouldn't be necessary to invent them: perverse incentives in drug development, research, marketing and clinical practice.
    Charlton BG
    Med Hypotheses; 2005; 65(6):1005-9. PubMed ID: 16182461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New agents in medical oncology and the risk of venous thromboembolism.
    Manzoni M; Bencardino K; Piovella F; Chatzileontiadou S; Delfanti S; Riccardi A; Danova M; Corazza GR
    J Exp Clin Cancer Res; 2007 Jun; 26(2):185-94. PubMed ID: 17725097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Turkish nurses' information about, and administration of, chemotherapeutic drugs.
    Kosgeroglu N; Ayranci U; Ozerdogan N; Demirustu C
    J Clin Nurs; 2006 Sep; 15(9):1179-87. PubMed ID: 16911059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.